Cough syrups recognized by WHO as substandard are not registered in Azerbaijan

The World Health Organization (WHO) has issued an alert to national pharmaceutical regulators around the world regarding 4 cough and cold syrups manufactured by the Indian company Maiden Pharmaceuticals. According to the October 6, WHO medical product alert, Promethazine Oral Solution BP, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, Magrip N Cold Syrup are substandard medical products. Substandard medical products are products that fail to meet either their quality standards or specifications. It should be noted that according to the registration database of Registration and Expertise Department of Analytical Expertise Center, the mentioned medical products are not registered in the territory of the Republic of Azerbaijan.